Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results.
Bigner DD, Brown MT, Friedman AH, Coleman RE, Akabani G, Friedman HS, Thorstad WL, McLendon RE, Bigner SH, Zhao XG, Pegram CN, Wikstrand CJ, Herndon JE 2nd, Vick NA, Paleologos N, Cokgor I, Provenzale JM, Zalutsky MR.
Bigner DD, et al. Among authors: friedman hs, friedman ah.
J Clin Oncol. 1998 Jun;16(6):2202-12. doi: 10.1200/JCO.1998.16.6.2202.
J Clin Oncol. 1998.
PMID: 9626222
Clinical Trial.